| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |